USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nova Chemicals (International) S.A.

USPTO PatentsView assignee record - 280 granted patents across 59 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nova ranks #1,483 of 49,997 tracked US assignees by granted-patent volume, with 280 patents across 59 technology areas.

#1,483
of 49,997 US assignees by volume
Top 3%
by Innovation Score (61.0/100)
20.3
avg claims per patent
-5%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1483 · Foreign Corporation #1,483 · 280 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MID 280 grants
  • TOP-DECILE #1,483/49,997
  • PHOTO-FINISH Anritsu
  • CPC-WIDE C08F · 59 areas
  • INNOV-STRONG 61.0/100
  • CLAIMS-DENSE 20.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT -5% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anritsu Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Nova

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nova's Innovation Score is 61.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Nova's grant cadence moved

Between 2020–2024, Nova Chemicals (International) S.A. received 126 grants versus 133 in 2015–2019 (-5% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2018 at 34 grants and bottomed in 2023 at 18. Lead class C08F accounts for 55.7% of the portfolio across 59 subclasses. Volume neighbours: Anritsu Company (#1,479) and Astrazeneca AB (#1,487).

Nova's three-year grant acceleration

From 2019–2021 to 2022–2024, Nova Chemicals (International) S.A. moved from 92 to 60 grants (0.65x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,306. See the growth leaderboard.

Who files at Nova's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nova holds 280 patents at rank #1,483, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Nova

By rank, the assignees closest to #1,483 in granted patent volume.

Leaders in C08F (Macromolecular Compounds Obtained BY Reactions Only Invol…)

Other assignees with the most granted patents in Nova's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nova, neither rank-band nor same-CPC leaders (those blocks stay above).

Nova's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1520253035 20152016201720182019202020212022202320242025 21
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Nova Chemicals (International) S.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 28 10.0%
2016 23 8.2%
2017 22 7.9%
2018 34 12.1%
2019 26 9.3%
2020 34 12.1%
2021 32 11.4%
2022 20 7.1%
2023 18 6.4%
2024 22 7.9%
2025partial year 21 7.5%

Which technologies does Nova Chemicals (International) S.A. patent most?

Top 15 of 59 technology areas

Where it ranks

Overall rank by patents

#1,483

of 49,997 tracked assignees

Innovation Score

61.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nova Chemicals (International) S.A.'s patent record in context - here's where to go next.

  • Nova Chemicals (International) S.A.'s lead technology class is C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds), 55.7% of its portfolio - see every assignee active in that class. Explore C08F
  • Ranked #1,483 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Nova Chemicals (International) S.A. against Anritsu Company, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 61.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.